Selective Androgen Receptor Modulator (SARM) Treatment Prevents Bone Loss and Reduces Body Fat in Ovariectomized Rats

By Kearbey Jeffrey   Gao Wenqing   Narayanan Ramesh   Fisher Scott   Wu Di   Miller Duane   Dalton James  

Pharmaceutical Research, Vol. 24, Iss. 2, 2007-02 ,pp. : 328-335

Springer Publishing Company

Access to resources Recommend Favorite

Inhibitors of Tyrosine Kinases in the Treatment of Psoriasis

By  

Current Pharmaceutical Design, Vol. 6, Iss. 9, 2000-06 ,pp. : 933-942

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 10, 2004-04 ,pp. : 1083-1091

Bentham Science Publishers

Access to resources Recommend Favorite

Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists

By Rossowski W.J.   Cheng B.-L.   Taylor J.E.   Datta R.   Coy D.H.  

European Journal of Pharmacology, Vol. 438, Iss. 3, 2002-03 ,pp. : 159-170

Elsevier

Access to resources Recommend Favorite

The effects of lignocaine and tetrodotoxin on the action potentials and contractions of left ventricles from normo- and hypertensive rats - accentuation during ischaemic perfusion

By Doggrell S.A.   Nand V.   Henderson C.J.  

General Pharmacology, Vol. 32, Iss. 4, 1999-04 ,pp. : 429-437

Elsevier

Access to resources Recommend Favorite